The Link Between Menopause and Alzheimer’s Disease: Understanding the Risks

Updated: Sep 7
Understanding the Link Between Menopause and Alzheimer’s Disease: A Comprehensive Guide
Dr. Christopher Zambakari, B.S., MBA, M.I.S., LP.D.
Owner/Operator; Desert Haven Home Care, Apollo Residential Assisted Living, Villa Fiore Assisted Living-Prescott Valley
Under a single home care umbrella, Desert Haven Home Care, Apollo Residential Assisted Living, and Villa Fiore Assisted Living-Prescott feature unparalleled care, service, and advocacy in the compassionate treatment of senior citizens in need of medical attention. Offered in a familial setting, the facilities are staffed by professionals passionate about their work and fully engaged in the welfare of residents. Each facility proudly provides patient-centric supervisory, assisted, and directed care, short-term respite stays, and memory care support for Alzheimer’s and dementia patients.
The Emotional Toll of Dementia
Paul Simon of Simon and Garfunkel fame wrote “Slip Slidin’ Away” in 1975. This melody reflects how quickly life can unravel. Be it a lost love, unfulfilled success, or promises not kept, each pales in comparison to the slip-sliding of dementia.
Dementia takes away everything we hold dear—memories, relationships, and our own life stories. Every three seconds, someone receives this heartbreaking diagnosis. It is the most feared condition among those aged 55 years and older. According to the Alzheimer’s Association, Alzheimer’s care in the U.S. costs $345 billion annually. Additionally, 11 million family members and caregivers provided unpaid care valued at $340 billion in 2022. This highlights the immense financial and personal burden of the disease.
Yet, more than just a “slidin’ away,” dementia is a catastrophic earthquake of heart-rending emotions. By 2060, approximately one million Americans could be diagnosed with some type of dementia annually, according to a study published in Nature Medicine. This compares with 514,000 cases in 2022. The study estimated the likelihood of developing dementia after age 55 is 42% and increases significantly to 56% for individuals over 85 years old.
Menopause as a Link to Alzheimer’s Disease
Recently, researchers and healthcare officials have been intrigued by the connection between menopause and Alzheimer’s disease—a form of dementia. This link was considered in a 2023 study by the Mayo Clinic.
Among the results, it was revealed that hormonal changes during menopause significantly impact brain health, potentially increasing the risk of Alzheimer’s in women. By 2050, two-thirds of the 13.8 million people in the U.S. likely to suffer from Alzheimer’s will be women. Understanding this link is crucial for prevention and treatment strategies.
The Role of Hormones in Cognitive Function
The role of estrogen in cognitive function is foundational. It acts as a “master regulator of bioenergetic systems in the brain and body,” according to the National Library of Medicine. Estrogen is vital for reproductive health and plays a neuroprotective role.
Estrogen enhances memory function and protects the brain from age-related decline. During menopause, estrogen levels drop, leading to metabolic and structural changes in the brain. These changes may predispose women to neurodegenerative diseases like Alzheimer’s. Other research suggests that an early decline in estrogen increases women’s risk of health issues such as cardiovascular disease, Parkinson’s, depression, osteoporosis, high blood pressure, weight gain, midlife diabetes, and cognitive disorders.
Early Menopause and Increased Alzheimer’s Risk
Neuroimaging studies reveal that menopause is associated with significant structural and functional changes in the brain. Additionally, early menopause (before age 45) or surgical menopause significantly raises the risk of Alzheimer’s disease. Early menopause retards estrogen’s neuroprotective benefits prematurely, leaving the brain more vulnerable to age-related damage. These changes may explain the increased vulnerability to Alzheimer’s disease.
Neuroimaging can show a loss of gray matter volume in the brain and shrinkage in memory-related brain regions during menopause. A decline in white matter integrity can occur, often disrupting communication across different regions of the brain. In postmenopausal women, decreased glucose metabolism has been evidenced, and networks aligned with memory and cognitive processing show disturbed connectivity during menopause.
These findings suggest that menopause may serve as an early biomarker for Alzheimer’s risk, reinforcing the need for proactive brain health strategies.
Positive Aspects of Menopause
On a brighter side, all is not lost. Lisa Mosconi, author of The Menopause Brain, has examined the neurological symptoms of menopause, including the new mental skills it can foster and the options for brain-inclusive menopause care. She writes that menopause can actually enhance emotional stability and self-confidence. Neurologically, a small part of the brain—the amygdala—becomes less reactive to negativity, leading to greater peace and life contentment. Many postmenopausal women also experience increased empathy and feel more comfortable in their own skin.
Prevention and Intervention Strategies
Given the growing evidence linking menopause and Alzheimer’s, targeted interventions can help mitigate risks. Healthcare providers agree that regular exercise can reduce the risk of succumbing to Alzheimer’s. Activities like reading, puzzles, and social interaction stimulate brain plasticity—the brain’s ability to modify its connections or rewire itself.
Proper diet—think Mediterranean—is associated with better cognitive aging. Because heart health is related to brain health, managing cholesterol, blood pressure, and diabetes risk are important prevention and intervention strategies.
Conclusion
The link between menopause and Alzheimer’s underscores the need for increased awareness and proactive health measures. Women should be informed about their unique risks and consider lifestyle, medical, and cognitive interventions to preserve brain health. As research progresses, a deeper understanding of this connection will pave the way for better prevention and treatment strategies.
About the Author
Dr. Christopher Zambakari is the owner and operator of three Arizona-based assisted living care homes – Desert Haven Home Care in Phoenix, Apollo Residential Assisted Living in Glendale, and Villa Fiore Assisted Living in Prescott Valley, Arizona. He provides direction and oversight to a team of licensed medical and caregiving professionals to ensure the highest levels of customized care, service, and advocacy at each of his facilities. Zambakari is founder and CEO of The Zambakari Advisory, an international consultancy in the areas of strategic intelligence, program design, and transitional processes. He is a Hartley B. and Ruth B. Barker Endowed Rotary Peace Fellow and the assistant editor of the Bulletin of The Sudans Studies Association.



Comments